A paper by Proudman et al. (2024) finds that doing so would be extremely expensive. Including all preclinical, clinical and post-approval R&D activities, total annual costs to maintain the average lifecycle level of 49.4 approved drugs across all disease areas during the 2018–22 period was estimated to be $139.6 billion. Including only pre-launch costs, total…
Carlyle and SK Capital Partners are buying beleaguered gene therapy biotech Bluebird Bio for about $29 million. Meanwhile, Pfizer continued the culling of its gene therapies with the discontinuation of Beqvez for hemophilia B. The post Cash-Strapped Gene Therapy Firm Bluebird Bio Agrees to Acquisition by Private Equity appeared first on MedCity News.
Hospitals are adopting AI technology more than ever before, but they still face challenges when it comes to measuring the impact of these solutions and scaling them, noted Kiran Mysore, chief data & analytics officer at Sutter Health. The post Hospitals Are Adopting AI — But Can They Measure and Scale These Tools? appeared first…
This fact sheet provides an overview of the history of the Kemp-Kasten amendment, which states that no U.S. funds may be made available to “any organization or program which, as determined by the president of the United States, supports or participates in the management of a program of coercive abortion or involuntary sterilization,” and examines…
Future Family launched a nationwide IVF insurance product on Wednesday. If families don’t achieve a live birth after two cycles of IVF, they can get their money back. The post Future Family Guarantees ‘Baby or Your Money Back’ with New Nationwide IVF Insurance appeared first on MedCity News.
Congressional lawmakers are facing tricky arithmetic as they hammer out a budget plan to finance President Donald Trump’s agenda. Republicans need to free up roughly $4 trillion to pay for renewing Trump’s 2017 tax cuts, which expire at the end of the year. Trump has vowed not to touch the costliest government programs, including Medicare…
Anna Taylor, the MultiCare ACO’s associate vice president of population health and value-based care, and Tuva Health CEO Aaron Neiderhiser discuss their partnership
The conversations in Nashville reinforced the idea that while innovation remains essential, vendors must navigate the fine balance between bold ideas and real-world implementation, demonstrating not just promise but tangible outcomes. The post ViVE 2025: The Crossroads of Digital Health Innovation and Realities appeared first on MedCity News.
Katherine Saunders is the co-founder and CMO at FlyteHealth. She was one of the first 20 obesity fellows in the US. FlyteHealth is the specialized online obesity clinic that resulted from her desire to scale what works for individuals to combat their obesity–by the time people get to FlyteHealth 99% of them are ready for…
Some private schools have shut down because of a rapidly escalating measles outbreak in West Texas. Local health departments are overstretched, pausing other important work as they race to limit the spread of this highly contagious virus. Since the outbreak emerged three weeks ago, the Texas health department has confirmed 90 cases with 16 hospitalizations,…